Live Earnings Conference Call: Clover Health Investments will host a live Q2 2026 earnings call on August 5, 2026 at 5:00PM ET. Follow this link to get details and listen to Clover Health Investments' Q2 2026 earnings call when it goes live. Get details. NASDAQ:CLOV Clover Health Investments (CLOV) Stock Price, News & Analysis $4.24 -0.03 (-0.70%) As of 11:52 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Clover Health Investments Stock (NASDAQ:CLOV) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CLOV alerts:Sign Up Key Stats Today's Range$4.16▼$4.3150-Day Range$3.59▼$5.4152-Week Range$1.58▼$5.59Volume925,956 shsAverage Volume6.45 million shsMarket Capitalization$2.23 billionP/E RatioN/ADividend YieldN/APrice Target$4.25Consensus RatingHold Company Overview Clover Health Investments is a technology-driven healthcare company specializing in Medicare Advantage plans for senior populations. The company combines insurance coverage with a proprietary software platform to improve care coordination, outcomes tracking and cost management. By leveraging data analytics, Clover Health aims to deliver personalized care pathways and preventive interventions for its members. At the core of Clover’s offering is its Clover Assistant platform, which aggregates clinical and claims data from multiple sources to create real-time insights for physicians and care teams. This platform flags gaps in care, offers evidence-based treatment suggestions and facilitates member outreach to ensure adherence to preventive screenings and chronic condition management. Clover’s insurance products cover hospitalization, outpatient care, prescription drug benefits and various supplemental services, including telehealth and transportation assistance. Founded in 2014 by Vivek Garipalli and Kris Gale and headquartered in Jersey City, New Jersey, Clover Health has expanded its Medicare Advantage footprint across several U.S. states. The company serves beneficiaries in urban and rural markets, with operations spanning regions such as the Northeast, Southeast and Midwest. Under the leadership of its co-founders, Clover continues to invest in data science, artificial intelligence and member engagement tools to drive clinical quality improvements and cost efficiencies throughout its network.AI Generated. May Contain Errors. Read More Clover Health Investments Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks20th Percentile Overall ScoreCLOV MarketRank™: Clover Health Investments scored higher than 20% of companies evaluated by MarketBeat, and ranked 803rd out of 900 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.6 / 5Analyst RatingHold Consensus RatingClover Health Investments has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 3 hold ratings, and 1 sell rating.Upside/DownsideThe consensus price target for Clover Health Investments is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageClover Health Investments has only been the subject of 3 research reports in the past 90 days.Read more about Clover Health Investments' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Clover Health Investments is -35.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Clover Health Investments is -35.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioClover Health Investments has a P/B Ratio of 7.24. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Clover Health Investments' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.14% of the float of Clover Health Investments has been sold short.Short Interest Ratio / Days to CoverClover Health Investments has a short interest ratio ("days to cover") of 4.89.Change versus previous monthShort interest in Clover Health Investments has recently increased by 29.59%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldClover Health Investments does not currently pay a dividend.Dividend GrowthClover Health Investments does not have a long track record of dividend growth. News and Social Media3.6 / 5News Sentiment0.83 News SentimentClover Health Investments has a news sentiment score of 0.83. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.64 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Clover Health Investments this week, compared to 4 articles on an average week.Search Interest21 people have searched for CLOV on MarketBeat in the last 30 days. This is an increase of 31% compared to the previous 30 days.MarketBeat Follows7 people have added Clover Health Investments to their MarketBeat watchlist in the last 30 days. This is an increase of 250% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Clover Health Investments insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,202,372.00 in company stock.Percentage Held by Insiders23.51% of the stock of Clover Health Investments is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions19.77% of the stock of Clover Health Investments is held by institutions.Read more about Clover Health Investments' insider trading history. Receive CLOV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Clover Health Investments and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CLOV Stock News HeadlinesIs Clover Health Finally Turning the Corner?August 3 at 7:30 AM | 247wallst.comClover Health's CEO Just Sold 62,711 Shares for Tax Withholding. The Bigger News Comes Next Week.July 31, 2026 | fool.comIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.August 5 at 1:00 AM | Banyan Hill Publishing (Ad)Clover Health to Participate in Upcoming Canaccord Genuity 46th Annual Growth ConferenceJuly 22, 2026 | globenewswire.comClover Health says employee accounts accessed in cyber incidentJuly 17, 2026 | reuters.comClover Health Investments (CLOV) Faces A Valuation Test Ahead Of August EarningsJuly 11, 2026 | finance.yahoo.comIs Clover Health Investments (CLOV) Reasonable After Its 3.8x Run?July 10, 2026 | finance.yahoo.comClover Health to Report Second Quarter 2026 Financial Results on August 5, 2026July 9, 2026 | globenewswire.comSee More Headlines CLOV Stock Analysis - Frequently Asked Questions How have CLOV shares performed this year? Clover Health Investments' stock was trading at $2.35 at the start of the year. Since then, CLOV shares have increased by 81.7% and is now trading at $4.27. How were Clover Health Investments' earnings last quarter? Clover Health Investments, Corp. (NASDAQ:CLOV) issued its quarterly earnings data on Wednesday, May, 6th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by $0.02. The firm earned $749.19 million during the quarter, compared to analyst estimates of $714.89 million. Clover Health Investments had a negative net margin of 2.58% and a negative trailing twelve-month return on equity of 16.52%. Read the conference call transcript. How do I buy shares of Clover Health Investments? Shares of CLOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Clover Health Investments own? Based on aggregate information from My MarketBeat watchlists, some other companies that Clover Health Investments investors own include Zomedica (ZOM), AMC Entertainment (AMC), SoFi Technologies (SOFI), Jumia Technologies (JMIA), NIO (NIO), Meta Platforms (META) and NVIDIA (NVDA). Company Calendar Last Earnings5/06/2026Today8/05/2026Next Earnings (Estimated)8/05/2026Canaccord Genuity's 46th Annual Growth Conference8/11/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3m+) 1-Year History Aug 25 Nov 25 Feb 26 May 26 Aug 26 CLOV's financial health is in the Green zone, according to TradeSmith. CLOV has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryManaged Healthcare Current SymbolNASDAQ:CLOV CIK1801170 Webwww.cloverhealth.com Phone201-432-2133FaxN/AEmployees680Year Founded2014Price Target and Rating Average Price Target for Clover Health Investments$4.25 High Price Target$5.50 Low Price Target$2.50 Potential Upside/Downside0.0%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($0.12) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$85.55 million Net Margins-2.58% Pretax Margin-2.58% Return on Equity-16.52% Return on Assets-9.28% Debt Debt-to-Equity RatioN/A Current Ratio1.33 Quick Ratio1.33 Sales & Book Value Annual Sales$1.92 billion Price / Sales1.16 Cash FlowN/A Price / Cash FlowN/A Book Value$0.59 per share Price / Book7.20Miscellaneous Outstanding Shares526,680,000Free Float402,861,000Market Cap$2.24 billion OptionableOptionable Beta2.47 Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NASDAQ:CLOV) was last updated on 8/5/2026 by MarketBeat.com Staff. From Our PartnersTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredDOJ Admits It In Court—Your Cash Can Be Seized Without WarningThe Department of Justice recently argued in court that cash may not be legally your property - raising concer...Priority Gold | SponsoredWhere to Put $100 Before Trump's New Tech Law Rolls OutThe Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...Brownstone Research | SponsoredWhat's the Best Way to Lower RMD Taxes?Once you turn 73, the IRS requires you to take distributions from your IRA, 401(k), and other retirement accou...SmartAsset | SponsoredThree oil giants buried the same discovery for 50 yearsIn 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clover Health Investments, Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clover Health Investments With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
